nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT3A—PRC2 methylates histones and DNA—PHF1—uterine cancer	0.0191	0.0783	CbGpPWpGaD
Decitabine—DNMT3A—decidua—uterine cancer	0.0155	0.075	CbGeAlD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—SUZ12—uterine cancer	0.0136	0.0558	CbGpPWpGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—PHF1—uterine cancer	0.0129	0.0529	CbGpPWpGaD
Decitabine—DNMT1—myometrium—uterine cancer	0.0126	0.0612	CbGeAlD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—PHF1—uterine cancer	0.0122	0.0502	CbGpPWpGaD
Decitabine—DNMT3A—female reproductive system—uterine cancer	0.0122	0.059	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—MEAF6—uterine cancer	0.012	0.0491	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—ARID1A—uterine cancer	0.0116	0.0477	CbGpPWpGaD
Decitabine—DNMT3A—female gonad—uterine cancer	0.0111	0.0537	CbGeAlD
Decitabine—DNMT3A—vagina—uterine cancer	0.011	0.0533	CbGeAlD
Decitabine—DNMT1—epithelium—uterine cancer	0.00992	0.048	CbGeAlD
Decitabine—DNMT1—uterine cervix—uterine cancer	0.00984	0.0476	CbGeAlD
Decitabine—DNMT1—decidua—uterine cancer	0.00937	0.0454	CbGeAlD
Decitabine—DNMT1—PRC2 methylates histones and DNA—SUZ12—uterine cancer	0.00917	0.0377	CbGpPWpGaD
Decitabine—Gemcitabine—POLD1—uterine cancer	0.0091	0.362	CrCbGaD
Decitabine—DNMT1—endometrium—uterine cancer	0.0089	0.0431	CbGeAlD
Decitabine—DCK—myometrium—uterine cancer	0.00874	0.0423	CbGeAlD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—SUZ12—uterine cancer	0.00871	0.0358	CbGpPWpGaD
Decitabine—DNMT1—mammalian vulva—uterine cancer	0.0086	0.0417	CbGeAlD
Decitabine—DNMT3A—One Carbon Metabolism—MTHFR—uterine cancer	0.00846	0.0347	CbGpPWpGaD
Decitabine—DNMT1—Epigenetic regulation of gene expression—PHF1—uterine cancer	0.00825	0.0339	CbGpPWpGaD
Decitabine—DNMT1—uterus—uterine cancer	0.0082	0.0397	CbGeAlD
Decitabine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—uterine cancer	0.0076	0.0312	CbGpPWpGaD
Decitabine—DNMT1—female reproductive system—uterine cancer	0.00737	0.0357	CbGeAlD
Decitabine—DNMT3A—lymph node—uterine cancer	0.00713	0.0345	CbGeAlD
Decitabine—DCK—uterine cervix—uterine cancer	0.0068	0.0329	CbGeAlD
Decitabine—DNMT1—female gonad—uterine cancer	0.00671	0.0325	CbGeAlD
Decitabine—DNMT1—vagina—uterine cancer	0.00666	0.0323	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—CHD4—uterine cancer	0.00656	0.0269	CbGpPWpGaD
Decitabine—DCK—decidua—uterine cancer	0.00648	0.0314	CbGeAlD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—EZH2—uterine cancer	0.00642	0.0264	CbGpPWpGaD
Decitabine—Cytarabine—POLD1—uterine cancer	0.00621	0.247	CrCbGaD
Decitabine—DCK—endometrium—uterine cancer	0.00615	0.0298	CbGeAlD
Decitabine—DCK—mammalian vulva—uterine cancer	0.00595	0.0288	CbGeAlD
Decitabine—DNMT1—Epigenetic regulation of gene expression—SUZ12—uterine cancer	0.00588	0.0241	CbGpPWpGaD
Decitabine—DNMT1—One Carbon Metabolism—MTHFR—uterine cancer	0.00571	0.0235	CbGpPWpGaD
Decitabine—DCK—uterus—uterine cancer	0.00567	0.0274	CbGeAlD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00554	0.0227	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN2B—uterine cancer	0.00527	0.0216	CbGpPWpGaD
Decitabine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—uterine cancer	0.00513	0.0211	CbGpPWpGaD
Decitabine—DCK—female reproductive system—uterine cancer	0.0051	0.0247	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—ARID1A—uterine cancer	0.00497	0.0204	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—SMAD3—uterine cancer	0.00481	0.0198	CbGpPWpGaD
Decitabine—DCK—female gonad—uterine cancer	0.00464	0.0225	CbGeAlD
Decitabine—DCK—vagina—uterine cancer	0.00461	0.0223	CbGeAlD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00458	0.0188	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00456	0.0187	CbGpPWpGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—EZH2—uterine cancer	0.00434	0.0178	CbGpPWpGaD
Decitabine—DNMT1—lymph node—uterine cancer	0.00431	0.0209	CbGeAlD
Decitabine—DCK—Nucleotide metabolism—RRM2—uterine cancer	0.00412	0.0169	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—EZH2—uterine cancer	0.00412	0.0169	CbGpPWpGaD
Decitabine—Clofarabine—RRM2—uterine cancer	0.00396	0.157	CrCbGaD
Decitabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.00382	0.38	CbGdCrCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00378	0.0155	CbGpPWpGaD
Decitabine—Gemcitabine—RRM2—uterine cancer	0.00362	0.144	CrCbGaD
Decitabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.00354	0.351	CbGdCrCtD
Decitabine—DCK—lymph node—uterine cancer	0.00298	0.0144	CbGeAlD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—uterine cancer	0.00288	0.0118	CbGpPWpGaD
Decitabine—DNMT1—Epigenetic regulation of gene expression—EZH2—uterine cancer	0.00278	0.0114	CbGpPWpGaD
Decitabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.0027	0.269	CbGdCrCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1B—uterine cancer	0.00267	0.011	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MET—uterine cancer	0.00257	0.0105	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—EP300—uterine cancer	0.00234	0.00963	CbGpPWpGaD
Decitabine—Cladribine—RRM2—uterine cancer	0.00227	0.0904	CrCbGaD
Decitabine—DNMT3A—Gene Expression—PHF1—uterine cancer	0.00204	0.00838	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—uterine cancer	0.00196	0.00806	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN1B—uterine cancer	0.00174	0.00714	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—CHD4—uterine cancer	0.00174	0.00713	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—EP300—uterine cancer	0.00153	0.00627	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—SUZ12—uterine cancer	0.00145	0.00597	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00139	0.00572	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PHF1—uterine cancer	0.00138	0.00566	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—CHD4—uterine cancer	0.00117	0.00482	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00115	0.00474	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—SUZ12—uterine cancer	0.000983	0.00404	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000876	0.00359	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—EP300—uterine cancer	0.000872	0.00358	CbGpPWpGaD
Decitabine—DCK—Metabolism—NDUFB11—uterine cancer	0.000791	0.00325	CbGpPWpGaD
Decitabine—DCK—Metabolism—SRD5A2—uterine cancer	0.000791	0.00325	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000725	0.00298	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PGR—uterine cancer	0.000725	0.00297	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—EZH2—uterine cancer	0.000688	0.00283	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—ESR2—uterine cancer	0.000638	0.00262	CbGpPWpGaD
Decitabine—Lethargy—Epirubicin—uterine cancer	0.000583	0.00113	CcSEcCtD
Decitabine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000583	0.00113	CcSEcCtD
Decitabine—Nausea—Progesterone—uterine cancer	0.000582	0.00113	CcSEcCtD
Decitabine—Hyponatraemia—Epirubicin—uterine cancer	0.000574	0.00112	CcSEcCtD
Decitabine—DCK—Metabolism—AKR1B1—uterine cancer	0.000572	0.00235	CbGpPWpGaD
Decitabine—DCK—Metabolism—STAR—uterine cancer	0.000572	0.00235	CbGpPWpGaD
Decitabine—Pain in extremity—Epirubicin—uterine cancer	0.000572	0.00111	CcSEcCtD
Decitabine—Feeling abnormal—Dactinomycin—uterine cancer	0.000571	0.00111	CcSEcCtD
Decitabine—Ill-defined disorder—Etoposide—uterine cancer	0.00057	0.00111	CcSEcCtD
Decitabine—Anaemia—Etoposide—uterine cancer	0.000568	0.0011	CcSEcCtD
Decitabine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000566	0.0011	CcSEcCtD
Decitabine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000565	0.0011	CcSEcCtD
Decitabine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00109	CcSEcCtD
Decitabine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00109	CcSEcCtD
Decitabine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00108	CcSEcCtD
Decitabine—Malaise—Etoposide—uterine cancer	0.000554	0.00108	CcSEcCtD
Decitabine—Leukopenia—Etoposide—uterine cancer	0.00055	0.00107	CcSEcCtD
Decitabine—Abdominal pain—Dactinomycin—uterine cancer	0.000547	0.00106	CcSEcCtD
Decitabine—Body temperature increased—Dactinomycin—uterine cancer	0.000547	0.00106	CcSEcCtD
Decitabine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000547	0.00106	CcSEcCtD
Decitabine—Lethargy—Doxorubicin—uterine cancer	0.00054	0.00105	CcSEcCtD
Decitabine—Cough—Etoposide—uterine cancer	0.000536	0.00104	CcSEcCtD
Decitabine—Dehydration—Epirubicin—uterine cancer	0.000532	0.00103	CcSEcCtD
Decitabine—Hyponatraemia—Doxorubicin—uterine cancer	0.000531	0.00103	CcSEcCtD
Decitabine—Hypertension—Etoposide—uterine cancer	0.00053	0.00103	CcSEcCtD
Decitabine—Pain in extremity—Doxorubicin—uterine cancer	0.000529	0.00103	CcSEcCtD
Decitabine—Liver function test abnormal—Epirubicin—uterine cancer	0.000528	0.00103	CcSEcCtD
Decitabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.00102	CcSEcCtD
Decitabine—Dry skin—Epirubicin—uterine cancer	0.000524	0.00102	CcSEcCtD
Decitabine—Chest pain—Etoposide—uterine cancer	0.000523	0.00102	CcSEcCtD
Decitabine—Abdominal pain upper—Epirubicin—uterine cancer	0.000522	0.00101	CcSEcCtD
Decitabine—Hypokalaemia—Epirubicin—uterine cancer	0.00052	0.00101	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000519	0.00101	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—CDKN2B—uterine cancer	0.000519	0.00213	CbGpPWpGaD
Decitabine—Discomfort—Etoposide—uterine cancer	0.000517	0.001	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000515	0.001	CcSEcCtD
Decitabine—Nasopharyngitis—Epirubicin—uterine cancer	0.000511	0.000993	CcSEcCtD
Decitabine—Hypersensitivity—Dactinomycin—uterine cancer	0.00051	0.000992	CcSEcCtD
Decitabine—Confusional state—Etoposide—uterine cancer	0.000505	0.000982	CcSEcCtD
Decitabine—Muscular weakness—Epirubicin—uterine cancer	0.000504	0.00098	CcSEcCtD
Decitabine—Anaphylactic shock—Etoposide—uterine cancer	0.000501	0.000974	CcSEcCtD
Decitabine—Infection—Etoposide—uterine cancer	0.000498	0.000968	CcSEcCtD
Decitabine—Abdominal distension—Epirubicin—uterine cancer	0.000497	0.000967	CcSEcCtD
Decitabine—Asthenia—Dactinomycin—uterine cancer	0.000497	0.000966	CcSEcCtD
Decitabine—Dysphagia—Epirubicin—uterine cancer	0.000494	0.00096	CcSEcCtD
Decitabine—Dehydration—Doxorubicin—uterine cancer	0.000492	0.000956	CcSEcCtD
Decitabine—Thrombocytopenia—Etoposide—uterine cancer	0.000491	0.000954	CcSEcCtD
Decitabine—DNMT1—Gene Expression—PGR—uterine cancer	0.000489	0.00201	CbGpPWpGaD
Decitabine—Tachycardia—Etoposide—uterine cancer	0.000489	0.000951	CcSEcCtD
Decitabine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000488	0.000949	CcSEcCtD
Decitabine—Skin disorder—Etoposide—uterine cancer	0.000487	0.000946	CcSEcCtD
Decitabine—Dry skin—Doxorubicin—uterine cancer	0.000485	0.000942	CcSEcCtD
Decitabine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000483	0.000939	CcSEcCtD
Decitabine—Hypokalaemia—Doxorubicin—uterine cancer	0.000481	0.000935	CcSEcCtD
Decitabine—Anorexia—Etoposide—uterine cancer	0.000478	0.000928	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000476	0.000926	CcSEcCtD
Decitabine—Bronchitis—Epirubicin—uterine cancer	0.000475	0.000923	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—SMAD3—uterine cancer	0.000474	0.00195	CbGpPWpGaD
Decitabine—Diarrhoea—Dactinomycin—uterine cancer	0.000474	0.000921	CcSEcCtD
Decitabine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000473	0.000919	CcSEcCtD
Decitabine—Pancytopenia—Epirubicin—uterine cancer	0.000469	0.000912	CcSEcCtD
Decitabine—Hypotension—Etoposide—uterine cancer	0.000468	0.00091	CcSEcCtD
Decitabine—Muscular weakness—Doxorubicin—uterine cancer	0.000467	0.000907	CcSEcCtD
Decitabine—DNMT1—Gene Expression—EZH2—uterine cancer	0.000465	0.00191	CbGpPWpGaD
Decitabine—Neutropenia—Epirubicin—uterine cancer	0.000462	0.000898	CcSEcCtD
Decitabine—Dysuria—Epirubicin—uterine cancer	0.000462	0.000898	CcSEcCtD
Decitabine—Abdominal distension—Doxorubicin—uterine cancer	0.00046	0.000894	CcSEcCtD
Decitabine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000459	0.000892	CcSEcCtD
Decitabine—Dysphagia—Doxorubicin—uterine cancer	0.000457	0.000888	CcSEcCtD
Decitabine—Pollakiuria—Epirubicin—uterine cancer	0.000456	0.000887	CcSEcCtD
Decitabine—DCK—Metabolism—POLD1—uterine cancer	0.000449	0.00184	CbGpPWpGaD
Decitabine—Weight decreased—Epirubicin—uterine cancer	0.000447	0.000869	CcSEcCtD
Decitabine—Dyspnoea—Etoposide—uterine cancer	0.000447	0.000868	CcSEcCtD
Decitabine—Hyperglycaemia—Epirubicin—uterine cancer	0.000446	0.000866	CcSEcCtD
Decitabine—Pneumonia—Epirubicin—uterine cancer	0.000443	0.000861	CcSEcCtD
Decitabine—Infestation—Epirubicin—uterine cancer	0.000441	0.000856	CcSEcCtD
Decitabine—Infestation NOS—Epirubicin—uterine cancer	0.000441	0.000856	CcSEcCtD
Decitabine—Vomiting—Dactinomycin—uterine cancer	0.00044	0.000856	CcSEcCtD
Decitabine—Bronchitis—Doxorubicin—uterine cancer	0.00044	0.000854	CcSEcCtD
Decitabine—Rash—Dactinomycin—uterine cancer	0.000437	0.000849	CcSEcCtD
Decitabine—Decreased appetite—Etoposide—uterine cancer	0.000436	0.000847	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—uterine cancer	0.000434	0.000844	CcSEcCtD
Decitabine—Renal failure—Epirubicin—uterine cancer	0.000433	0.000842	CcSEcCtD
Decitabine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000433	0.000841	CcSEcCtD
Decitabine—Fatigue—Etoposide—uterine cancer	0.000432	0.00084	CcSEcCtD
Decitabine—DNMT1—Gene Expression—ESR2—uterine cancer	0.000431	0.00177	CbGpPWpGaD
Decitabine—Stomatitis—Epirubicin—uterine cancer	0.000429	0.000834	CcSEcCtD
Decitabine—Constipation—Etoposide—uterine cancer	0.000429	0.000833	CcSEcCtD
Decitabine—Pain—Etoposide—uterine cancer	0.000429	0.000833	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—uterine cancer	0.000428	0.000832	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—uterine cancer	0.000428	0.000831	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—uterine cancer	0.000428	0.000831	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000425	0.000826	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—uterine cancer	0.000422	0.000821	CcSEcCtD
Decitabine—DCK—Metabolism—AKR1C1—uterine cancer	0.00042	0.00172	CbGpPWpGaD
Decitabine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000417	0.00081	CcSEcCtD
Decitabine—Epistaxis—Epirubicin—uterine cancer	0.000416	0.000807	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—uterine cancer	0.000414	0.000804	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—uterine cancer	0.000413	0.000803	CcSEcCtD
Decitabine—Feeling abnormal—Etoposide—uterine cancer	0.000413	0.000803	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000412	0.000801	CcSEcCtD
Decitabine—Nausea—Dactinomycin—uterine cancer	0.000411	0.000799	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—uterine cancer	0.00041	0.000797	CcSEcCtD
Decitabine—Gastrointestinal pain—Etoposide—uterine cancer	0.00041	0.000796	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—uterine cancer	0.000408	0.000792	CcSEcCtD
Decitabine—Infestation—Doxorubicin—uterine cancer	0.000408	0.000792	CcSEcCtD
Decitabine—Renal failure—Doxorubicin—uterine cancer	0.000401	0.000779	CcSEcCtD
Decitabine—Urticaria—Etoposide—uterine cancer	0.000398	0.000774	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—uterine cancer	0.000397	0.000772	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—uterine cancer	0.000397	0.000772	CcSEcCtD
Decitabine—Body temperature increased—Etoposide—uterine cancer	0.000396	0.00077	CcSEcCtD
Decitabine—Abdominal pain—Etoposide—uterine cancer	0.000396	0.00077	CcSEcCtD
Decitabine—Urinary tract infection—Doxorubicin—uterine cancer	0.000396	0.00077	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—uterine cancer	0.000395	0.000768	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—uterine cancer	0.000394	0.000765	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—uterine cancer	0.000393	0.000763	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—uterine cancer	0.000391	0.000759	CcSEcCtD
Decitabine—Oedema peripheral—Epirubicin—uterine cancer	0.00039	0.000757	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—uterine cancer	0.000389	0.000755	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—uterine cancer	0.000388	0.000753	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—ESR1—uterine cancer	0.000387	0.00159	CbGpPWpGaD
Decitabine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000386	0.000749	CcSEcCtD
Decitabine—Epistaxis—Doxorubicin—uterine cancer	0.000384	0.000747	CcSEcCtD
Decitabine—Sinusitis—Doxorubicin—uterine cancer	0.000382	0.000743	CcSEcCtD
Decitabine—DCK—Metabolism—RRM2—uterine cancer	0.000374	0.00154	CbGpPWpGaD
Decitabine—Eye disorder—Epirubicin—uterine cancer	0.00037	0.000718	CcSEcCtD
Decitabine—Hypersensitivity—Etoposide—uterine cancer	0.000369	0.000718	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—uterine cancer	0.000368	0.000715	CcSEcCtD
Decitabine—Cardiac disorder—Epirubicin—uterine cancer	0.000367	0.000713	CcSEcCtD
Decitabine—Haemorrhage—Doxorubicin—uterine cancer	0.000366	0.000711	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000364	0.000707	CcSEcCtD
Decitabine—DCK—Metabolism—DCN—uterine cancer	0.000363	0.00149	CbGpPWpGaD
Decitabine—Pharyngitis—Doxorubicin—uterine cancer	0.000363	0.000706	CcSEcCtD
Decitabine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000361	0.000702	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—uterine cancer	0.00036	0.0007	CcSEcCtD
Decitabine—Asthenia—Etoposide—uterine cancer	0.00036	0.000699	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—uterine cancer	0.00036	0.000699	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—uterine cancer	0.000359	0.000697	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—uterine cancer	0.000359	0.000697	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—uterine cancer	0.000357	0.000694	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—uterine cancer	0.000356	0.000693	CcSEcCtD
Decitabine—Chills—Epirubicin—uterine cancer	0.000355	0.00069	CcSEcCtD
Decitabine—Pruritus—Etoposide—uterine cancer	0.000355	0.000689	CcSEcCtD
Decitabine—DNMT1—Gene Expression—CDKN2B—uterine cancer	0.000351	0.00144	CbGpPWpGaD
Decitabine—Alopecia—Epirubicin—uterine cancer	0.000349	0.000679	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—uterine cancer	0.000346	0.000673	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—uterine cancer	0.000344	0.000669	CcSEcCtD
Decitabine—Erythema—Epirubicin—uterine cancer	0.000344	0.000669	CcSEcCtD
Decitabine—Diarrhoea—Etoposide—uterine cancer	0.000343	0.000666	CcSEcCtD
Decitabine—DCK—Metabolism—CYP11A1—uterine cancer	0.000342	0.00141	CbGpPWpGaD
Decitabine—Eye disorder—Doxorubicin—uterine cancer	0.000342	0.000665	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—uterine cancer	0.00034	0.00066	CcSEcCtD
Decitabine—Back pain—Epirubicin—uterine cancer	0.000333	0.000647	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—uterine cancer	0.000332	0.000645	CcSEcCtD
Decitabine—Dizziness—Etoposide—uterine cancer	0.000331	0.000644	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—uterine cancer	0.000331	0.000643	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—uterine cancer	0.000331	0.000642	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—uterine cancer	0.00033	0.000641	CcSEcCtD
Decitabine—Chills—Doxorubicin—uterine cancer	0.000328	0.000638	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—uterine cancer	0.000324	0.00063	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—uterine cancer	0.000323	0.000628	CcSEcCtD
Decitabine—DCK—Metabolism—AKR1C3—uterine cancer	0.000323	0.00133	CbGpPWpGaD
Decitabine—Mental disorder—Doxorubicin—uterine cancer	0.000321	0.000623	CcSEcCtD
Decitabine—DNMT1—Gene Expression—SMAD3—uterine cancer	0.00032	0.00131	CbGpPWpGaD
Decitabine—Ill-defined disorder—Epirubicin—uterine cancer	0.000319	0.000621	CcSEcCtD
Decitabine—Vomiting—Etoposide—uterine cancer	0.000319	0.000619	CcSEcCtD
Decitabine—Erythema—Doxorubicin—uterine cancer	0.000319	0.000619	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—uterine cancer	0.000319	0.000619	CcSEcCtD
Decitabine—Anaemia—Epirubicin—uterine cancer	0.000318	0.000618	CcSEcCtD
Decitabine—Rash—Etoposide—uterine cancer	0.000316	0.000614	CcSEcCtD
Decitabine—Dermatitis—Etoposide—uterine cancer	0.000316	0.000614	CcSEcCtD
Decitabine—Headache—Etoposide—uterine cancer	0.000314	0.00061	CcSEcCtD
Decitabine—Malaise—Epirubicin—uterine cancer	0.00031	0.000603	CcSEcCtD
Decitabine—Leukopenia—Epirubicin—uterine cancer	0.000308	0.000599	CcSEcCtD
Decitabine—Back pain—Doxorubicin—uterine cancer	0.000308	0.000599	CcSEcCtD
Decitabine—Muscle spasms—Doxorubicin—uterine cancer	0.000306	0.000595	CcSEcCtD
Decitabine—Cough—Epirubicin—uterine cancer	0.0003	0.000584	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—uterine cancer	0.0003	0.000583	CcSEcCtD
Decitabine—Nausea—Etoposide—uterine cancer	0.000298	0.000579	CcSEcCtD
Decitabine—Hypertension—Epirubicin—uterine cancer	0.000297	0.000578	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000296	0.000574	CcSEcCtD
Decitabine—Anaemia—Doxorubicin—uterine cancer	0.000294	0.000572	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—uterine cancer	0.000293	0.00057	CcSEcCtD
Decitabine—Chest pain—Epirubicin—uterine cancer	0.000293	0.00057	CcSEcCtD
Decitabine—Myalgia—Epirubicin—uterine cancer	0.000293	0.00057	CcSEcCtD
Decitabine—Anxiety—Epirubicin—uterine cancer	0.000292	0.000568	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000291	0.000566	CcSEcCtD
Decitabine—Discomfort—Epirubicin—uterine cancer	0.00029	0.000563	CcSEcCtD
Decitabine—Malaise—Doxorubicin—uterine cancer	0.000287	0.000558	CcSEcCtD
Decitabine—Leukopenia—Doxorubicin—uterine cancer	0.000285	0.000554	CcSEcCtD
Decitabine—Confusional state—Epirubicin—uterine cancer	0.000283	0.000551	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—uterine cancer	0.000281	0.000546	CcSEcCtD
Decitabine—Oedema—Epirubicin—uterine cancer	0.000281	0.000546	CcSEcCtD
Decitabine—Infection—Epirubicin—uterine cancer	0.000279	0.000542	CcSEcCtD
Decitabine—Cough—Doxorubicin—uterine cancer	0.000278	0.00054	CcSEcCtD
Decitabine—Nervous system disorder—Epirubicin—uterine cancer	0.000276	0.000535	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—uterine cancer	0.000275	0.000535	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—uterine cancer	0.000275	0.000534	CcSEcCtD
Decitabine—Tachycardia—Epirubicin—uterine cancer	0.000274	0.000533	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—uterine cancer	0.000273	0.00053	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—uterine cancer	0.000271	0.000527	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—uterine cancer	0.000271	0.000527	CcSEcCtD
Decitabine—Arthralgia—Doxorubicin—uterine cancer	0.000271	0.000527	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—uterine cancer	0.00027	0.000525	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000269	0.000523	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—uterine cancer	0.000268	0.000521	CcSEcCtD
Decitabine—Anorexia—Epirubicin—uterine cancer	0.000268	0.00052	CcSEcCtD
Decitabine—Hypotension—Epirubicin—uterine cancer	0.000263	0.00051	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—uterine cancer	0.000262	0.000509	CcSEcCtD
Decitabine—DNMT1—Gene Expression—ESR1—uterine cancer	0.000261	0.00107	CbGpPWpGaD
Decitabine—Anaphylactic shock—Doxorubicin—uterine cancer	0.00026	0.000505	CcSEcCtD
Decitabine—Oedema—Doxorubicin—uterine cancer	0.00026	0.000505	CcSEcCtD
Decitabine—Infection—Doxorubicin—uterine cancer	0.000258	0.000502	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000256	0.000497	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—uterine cancer	0.000255	0.000495	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000255	0.000495	CcSEcCtD
Decitabine—Insomnia—Epirubicin—uterine cancer	0.000254	0.000494	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—uterine cancer	0.000254	0.000493	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—uterine cancer	0.000253	0.000491	CcSEcCtD
Decitabine—DCK—Metabolism—CYP19A1—uterine cancer	0.000252	0.00103	CbGpPWpGaD
Decitabine—DCK—Metabolism—STK11—uterine cancer	0.000252	0.00103	CbGpPWpGaD
Decitabine—Dyspnoea—Epirubicin—uterine cancer	0.000251	0.000487	CcSEcCtD
Decitabine—Anorexia—Doxorubicin—uterine cancer	0.000248	0.000482	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—uterine cancer	0.000247	0.000481	CcSEcCtD
Decitabine—Decreased appetite—Epirubicin—uterine cancer	0.000244	0.000475	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—uterine cancer	0.000243	0.000472	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000243	0.000471	CcSEcCtD
Decitabine—Fatigue—Epirubicin—uterine cancer	0.000242	0.000471	CcSEcCtD
Decitabine—Constipation—Epirubicin—uterine cancer	0.00024	0.000467	CcSEcCtD
Decitabine—Pain—Epirubicin—uterine cancer	0.00024	0.000467	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000237	0.00046	CcSEcCtD
Decitabine—Insomnia—Doxorubicin—uterine cancer	0.000235	0.000457	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—uterine cancer	0.000232	0.00045	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—uterine cancer	0.000232	0.00045	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00023	0.000446	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—uterine cancer	0.000229	0.000445	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—uterine cancer	0.000226	0.000439	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000224	0.000436	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—uterine cancer	0.000224	0.000436	CcSEcCtD
Decitabine—Urticaria—Epirubicin—uterine cancer	0.000223	0.000434	CcSEcCtD
Decitabine—Constipation—Doxorubicin—uterine cancer	0.000222	0.000432	CcSEcCtD
Decitabine—Pain—Doxorubicin—uterine cancer	0.000222	0.000432	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—uterine cancer	0.000222	0.000432	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—uterine cancer	0.000222	0.000432	CcSEcCtD
Decitabine—Feeling abnormal—Doxorubicin—uterine cancer	0.000214	0.000416	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000213	0.000413	CcSEcCtD
Decitabine—Hypersensitivity—Epirubicin—uterine cancer	0.000207	0.000402	CcSEcCtD
Decitabine—Urticaria—Doxorubicin—uterine cancer	0.000207	0.000401	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—uterine cancer	0.000206	0.000399	CcSEcCtD
Decitabine—Body temperature increased—Doxorubicin—uterine cancer	0.000206	0.000399	CcSEcCtD
Decitabine—Asthenia—Epirubicin—uterine cancer	0.000202	0.000392	CcSEcCtD
Decitabine—Pruritus—Epirubicin—uterine cancer	0.000199	0.000386	CcSEcCtD
Decitabine—Diarrhoea—Epirubicin—uterine cancer	0.000192	0.000374	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—uterine cancer	0.000192	0.000372	CcSEcCtD
Decitabine—DCK—Metabolism—MTHFR—uterine cancer	0.000189	0.000777	CbGpPWpGaD
Decitabine—Asthenia—Doxorubicin—uterine cancer	0.000187	0.000362	CcSEcCtD
Decitabine—Dizziness—Epirubicin—uterine cancer	0.000186	0.000361	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—uterine cancer	0.000184	0.000357	CcSEcCtD
Decitabine—Vomiting—Epirubicin—uterine cancer	0.000179	0.000347	CcSEcCtD
Decitabine—Diarrhoea—Doxorubicin—uterine cancer	0.000178	0.000346	CcSEcCtD
Decitabine—Rash—Epirubicin—uterine cancer	0.000177	0.000344	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—uterine cancer	0.000177	0.000344	CcSEcCtD
Decitabine—Headache—Epirubicin—uterine cancer	0.000176	0.000342	CcSEcCtD
Decitabine—Dizziness—Doxorubicin—uterine cancer	0.000172	0.000334	CcSEcCtD
Decitabine—Nausea—Epirubicin—uterine cancer	0.000167	0.000324	CcSEcCtD
Decitabine—Vomiting—Doxorubicin—uterine cancer	0.000165	0.000321	CcSEcCtD
Decitabine—Rash—Doxorubicin—uterine cancer	0.000164	0.000319	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—uterine cancer	0.000164	0.000318	CcSEcCtD
Decitabine—Headache—Doxorubicin—uterine cancer	0.000163	0.000316	CcSEcCtD
Decitabine—Nausea—Doxorubicin—uterine cancer	0.000154	0.0003	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—AKT1—uterine cancer	0.00014	0.000573	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTEN—uterine cancer	0.000105	0.000432	CbGpPWpGaD
Decitabine—DCK—Metabolism—EP300—uterine cancer	0.0001	0.000412	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—AKT1—uterine cancer	9.43e-05	0.000387	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CA—uterine cancer	7.43e-05	0.000305	CbGpPWpGaD
Decitabine—DCK—Metabolism—AKT1—uterine cancer	6.07e-05	0.000249	CbGpPWpGaD
